 | • レポートコード：QAF27852 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のポリオワクチン市場について種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別（公共用、個人用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ポリオワクチン市場の概要 ・世界の主要地域別ポリオワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のポリオワクチン市場規模2016-2021：種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）） ・世界のポリオワクチン市場予測2012-2027：種類別（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）） ・世界のポリオワクチン市場規模2016-2021：用途別（公共用、個人用） ・世界のポリオワクチン市場予測2012-2027：用途別（公共用、個人用） ・ポリオワクチンのアメリカ市場規模と予測2016-2021 ・ポリオワクチンのヨーロッパ市場規模と予測2016-2021 ・ポリオワクチンの中国市場規模と予測2016-2021 ・ポリオワクチンの日本市場規模と予測2016-2021 ・ポリオワクチンの東南アジア市場規模と予測2016-2021 ・ポリオワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals） ・ポリオワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ポリオワクチンの市場動向・機会・課題 ・調査の結論 |
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
Market Analysis and Insights: Global Polio Vaccine Market
The global Polio Vaccine market was valued at US$ 1504.9 in 2020 and will reach US$ 2051.6 million by the end of 2027, growing at a CAGR of 5.3% during 2022-2027.
Global Polio Vaccine Scope and Market Size
The global Polio Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polio Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
The Polio Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Polio Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Polio Vaccine Market Overview
1.1 Polio Vaccine Product Scope
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Global Polio Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Public
1.3.3 Private
1.4 Polio Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Polio Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Polio Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Polio Vaccine Price Trends (2016-2027)
2 Polio Vaccine Estimates and Forecasts by Region
2.1 Global Polio Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Polio Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Polio Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Polio Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Polio Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Polio Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Polio Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Polio Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Polio Vaccine Estimates and Projections (2016-2027)
2.4.3 China Polio Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Polio Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Polio Vaccine Estimates and Projections (2016-2027)
2.4.6 India Polio Vaccine Estimates and Projections (2016-2027)
3 Global Polio Vaccine Competition Landscape by Players
3.1 Global Top Polio Vaccine Players by Sales (2016-2021)
3.2 Global Top Polio Vaccine Players by Revenue (2016-2021)
3.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio Vaccine as of 2020)
3.4 Global Polio Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Polio Vaccine Market Size by Type
4.1 Global Polio Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Polio Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Polio Vaccine Price by Type (2016-2021)
4.2 Global Polio Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Polio Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Polio Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Polio Vaccine Price Forecast by Type (2022-2027)
5 Global Polio Vaccine Market Size by Application
5.1 Global Polio Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Polio Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Polio Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Polio Vaccine Price by Application (2016-2021)
5.2 Global Polio Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Polio Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Polio Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Polio Vaccine Price Forecast by Application (2022-2027)
6 North America Polio Vaccine Market Facts & Figures
6.1 North America Polio Vaccine Sales by Company
6.1.1 North America Polio Vaccine Sales by Company (2016-2021)
6.1.2 North America Polio Vaccine Revenue by Company (2016-2021)
6.2 North America Polio Vaccine Sales Breakdown by Type
6.2.1 North America Polio Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Polio Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Polio Vaccine Sales Breakdown by Application
6.3.1 North America Polio Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Polio Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Polio Vaccine Market Facts & Figures
7.1 Europe Polio Vaccine Sales by Company
7.1.1 Europe Polio Vaccine Sales by Company (2016-2021)
7.1.2 Europe Polio Vaccine Revenue by Company (2016-2021)
7.2 Europe Polio Vaccine Sales Breakdown by Type
7.2.1 Europe Polio Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Polio Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Polio Vaccine Sales Breakdown by Application
7.3.1 Europe 132 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 132 Sales Breakdown by Application (2022-2027)
8 China Polio Vaccine Market Facts & Figures
8.1 China Polio Vaccine Sales by Company
8.1.1 China Polio Vaccine Sales by Company (2016-2021)
8.1.2 China Polio Vaccine Revenue by Company (2016-2021)
8.2 China Polio Vaccine Sales Breakdown by Type
8.2.1 China Polio Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Polio Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Polio Vaccine Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Polio Vaccine Market Facts & Figures
9.1 Japan Polio Vaccine Sales by Company
9.1.1 Japan Polio Vaccine Sales by Company (2016-2021)
9.1.2 Japan Polio Vaccine Revenue by Company (2016-2021)
9.2 Japan Polio Vaccine Sales Breakdown by Type
9.2.1 Japan Polio Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Polio Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Polio Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Polio Vaccine Market Facts & Figures
10.1 Southeast Asia Polio Vaccine Sales by Company
10.1.1 Southeast Asia Polio Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Polio Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Polio Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Polio Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Polio Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Polio Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Polio Vaccine Market Facts & Figures
11.1 India Polio Vaccine Sales by Company
11.1.1 India Polio Vaccine Sales by Company (2016-2021)
11.1.2 India Polio Vaccine Revenue by Company (2016-2021)
11.2 India Polio Vaccine Sales Breakdown by Type
11.2.1 India Polio Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Polio Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Polio Vaccine Sales Breakdown by Application
11.3.1 India Polio Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Polio Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Polio Vaccine Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Polio Vaccine Products Offered
12.1.5 Sanofi Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Polio Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Bibcol
12.3.1 Bibcol Corporation Information
12.3.2 Bibcol Business Overview
12.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bibcol Polio Vaccine Products Offered
12.3.5 Bibcol Recent Development
12.4 Serum Institute
12.4.1 Serum Institute Corporation Information
12.4.2 Serum Institute Business Overview
12.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Serum Institute Polio Vaccine Products Offered
12.4.5 Serum Institute Recent Development
12.5 Tiantan Biological
12.5.1 Tiantan Biological Corporation Information
12.5.2 Tiantan Biological Business Overview
12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Tiantan Biological Polio Vaccine Products Offered
12.5.5 Tiantan Biological Recent Development
12.6 IMBCA
12.6.1 IMBCA Corporation Information
12.6.2 IMBCA Business Overview
12.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 IMBCA Polio Vaccine Products Offered
12.6.5 IMBCA Recent Development
12.7 Panacea Biotec Ltd
12.7.1 Panacea Biotec Ltd Corporation Information
12.7.2 Panacea Biotec Ltd Business Overview
12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Panacea Biotec Ltd Polio Vaccine Products Offered
12.7.5 Panacea Biotec Ltd Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Corporation Information
12.8.2 Bio-Med Business Overview
12.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bio-Med Polio Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 Halfkin Bio-Pharmaceuticals
12.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
12.9.2 Halfkin Bio-Pharmaceuticals Business Overview
12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Products Offered
12.9.5 Halfkin Bio-Pharmaceuticals Recent Development
13 Polio Vaccine Manufacturing Cost Analysis
13.1 Polio Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Polio Vaccine
13.4 Polio Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Polio Vaccine Distributors List
14.3 Polio Vaccine Customers
15 Market Dynamics
15.1 Polio Vaccine Market Trends
15.2 Polio Vaccine Drivers
15.3 Polio Vaccine Market Challenges
15.4 Polio Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Polio Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Polio Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Polio Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Polio Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Polio Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Polio Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Polio Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Polio Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Polio Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Polio Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Polio Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Polio Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Polio Vaccine Sales Share by Company (2016-2021)
Table 14. Global Polio Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Polio Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2020)
Table 17. Global Polio Vaccine Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Polio Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Polio Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Polio Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Polio Vaccine Sales Share by Type (2016-2021)
Table 23. Global Polio Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Polio Vaccine Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Polio Vaccine Sales Share by Type (2022-2027)
Table 26. Global Polio Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Polio Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Polio Vaccine Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Polio Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Polio Vaccine Sales Share by Application (2016-2021)
Table 31. Global Polio Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Polio Vaccine Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Polio Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Polio Vaccine Sales Share by Application (2022-2027)
Table 35. Global Polio Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Polio Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Polio Vaccine Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Polio Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Polio Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Polio Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Polio Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Polio Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Polio Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Polio Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Polio Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Polio Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Polio Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Polio Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Polio Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Polio Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Polio Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Polio Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Polio Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Polio Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Polio Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Polio Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Polio Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Polio Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Polio Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Polio Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Polio Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Polio Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Polio Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Polio Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Polio Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Polio Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Polio Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Polio Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Polio Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Polio Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Polio Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Polio Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Polio Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Polio Vaccine Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Sanofi Polio Vaccine Product
Table 114. Sanofi Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. GSK Polio Vaccine Product
Table 119. GSK Recent Development
Table 120. Bibcol Corporation Information
Table 121. Bibcol Description and Business Overview
Table 122. Bibcol Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Bibcol Polio Vaccine Product
Table 124. Bibcol Recent Development
Table 125. Serum Institute Corporation Information
Table 126. Serum Institute Description and Business Overview
Table 127. Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Serum Institute Polio Vaccine Product
Table 129. Serum Institute Recent Development
Table 130. Tiantan Biological Corporation Information
Table 131. Tiantan Biological Description and Business Overview
Table 132. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Tiantan Biological Polio Vaccine Product
Table 134. Tiantan Biological Recent Development
Table 135. IMBCA Corporation Information
Table 136. IMBCA Description and Business Overview
Table 137. IMBCA Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. IMBCA Polio Vaccine Product
Table 139. IMBCA Recent Development
Table 140. Panacea Biotec Ltd Corporation Information
Table 141. Panacea Biotec Ltd Description and Business Overview
Table 142. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 143. Panacea Biotec Ltd Polio Vaccine Product
Table 144. Panacea Biotec Ltd Recent Development
Table 145. Bio-Med Corporation Information
Table 146. Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 147. Bio-Med Description and Business Overview
Table 148. Bio-Med Polio Vaccine Product
Table 149. Bio-Med Recent Development
Table 150. Halfkin Bio-Pharmaceuticals Corporation Information
Table 151. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 152. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 153. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
Table 154. Halfkin Bio-Pharmaceuticals Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Polio Vaccine Distributors List
Table 158. Polio Vaccine Customers List
Table 159. Polio Vaccine Market Trends
Table 160. Polio Vaccine Market Drivers
Table 161. Polio Vaccine Market Challenges
Table 162. Polio Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Polio Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Public Examples
Figure 7. Private Examples
Figure 8. Global Polio Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Polio Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Polio Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Polio Vaccine Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 12. Global Polio Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Polio Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Polio Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Polio Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Polio Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Polio Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Polio Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Polio Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Polio Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Polio Vaccine Players Market Share by Revenue in Polio Vaccine: 2016 & 2020
Figure 27. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Polio Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Polio Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Polio Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Polio Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Polio Vaccine Sales Market Share by Type in 2020
Figure 33. North America Polio Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Polio Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Polio Vaccine Sales Market Share by Application in 2020
Figure 36. China Polio Vaccine Sales Market Share by Type in 2020
Figure 37. China Polio Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Polio Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Polio Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Polio Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Polio Vaccine Sales Market Share by Application in 2020
Figure 42. India Polio Vaccine Sales Market Share by Type in 2020
Figure 43. India Polio Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Polio Vaccine
Figure 46. Manufacturing Process Analysis of Polio Vaccine
Figure 47. Polio Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
ポリオ（灰白髄炎）ワクチンのグローバル市場調査 2019年 The global Polio (Poliomyelitis) Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polio (Poliomyelitis) Vaccines volume and value at global level, regional level and company level. From a gl…- ポリオ（灰白髄炎）ワクチンのグローバル市場調査 2019年 The global Polio (Poliomyelitis) Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polio (Poliomyelitis) Vaccines volume and value at global level, regional level and company level. From a gl…
- ポリオウイルスワクチンのグローバル市場調査 2019年 The global Poliovirus Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Poliovirus Vaccine volume and value at global level, regional level and company level. From a global perspective, this r…
- ポリオウイルスワクチンのグローバル市場調査 2019年 The global Poliovirus Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Poliovirus Vaccine volume and value at global level, regional level and company level. From a global perspective, this r…
- 人用ワクチンのグローバル市場2021 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …